Tag: Lord Freyberg

The below Parliamentary question was asked by Lord Freyberg on 2016-01-13.

To ask Her Majesty’s Government what are the latest figures for the total number and percentage of incidence of cancers and total deaths excluding non-melanoma skin cancer, for (1) the top five occurring cancers, including breast, prostate, colorectal, lung, and melanoma, (2) less common cancers with an incidence ranked six to 15 by the International Classification of Diseases code, and (3) all other lower incidence cancers.

Lord Bridges of Headley

The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.

The below Parliamentary question was asked by Lord Freyberg on 2016-02-08.

To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 February (HL5344), when Genomic England expects to have reported back to patients from the pilot phase on (1) 100 patients, (2) 250 patients, (3) 500 patients, (4) 1000 patients, and (5) all patients.

Earl of Courtown

The existing bilateral programme fund, run by our Embassy in Pyongyang, has contributed to a number of projects aimed at improving the lives of some of the most vulnerable people in the Democratic People’s Republic of Korea (DPRK). These include helping to improve food and nutrition for people in rural areas and equipment for the physically disabled. In addition, our funding of English language projects and visits to the UK for government officials, exposes DPRK citizens to other values and cultures. We assess that many of our existing projects contain a human rights element, without strictly being defined as a human rights project. In the coming year we will continue to fund such projects where possible and will assess future human rights projects under the Magna Carta Fund for Human Rights and Democracy. The amount spent on projects categorised as containing a human rights element between 3 September 2013-8 October 2015 was £270,046.61.

The below Parliamentary question was asked by Lord Freyberg on 2016-05-23.

To ask Her Majesty’s Government what research they have carried out into levels of NO2 emissions by diesel trains in urban areas, and whether they intend to apply similar control measures for diesel trains as have been agreed for road vehicles.

Lord Ahmad of Wimbledon

The air quality plan for nitrogen dioxide we published in December 2015 sets out a comprehensive approach to improving the UK’s air quality, reducing health impacts, and fulfilling our legal obligations. The analysis undertaken for the plan took account of the emissions from rail travel as part of the assessment of emission sources.

Whilst emissions from the rail sector are relatively low, the air quality plan set out that UK is committed to reducing them even further, along with some of the steps we are taking. For example, the Government has committed to a major rail electrification programme that will see a significant number of diesel trains progressively replaced with electric equivalents.

The below Parliamentary question was asked by Lord Freyberg on 2016-09-05.

To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 25 July (HL1340), what date has been agreed by NICE for a full technology appraisal of lenvatinib.

Lord Prior of Brampton

Ministers asked the National Institute for Health and Care Excellence (NICE) to develop technology appraisal guidance on the use of lenvatinb for the treatment of thyroid cancer on 22 July 2016. NICE plans to develop guidance on lenvatinib and sorafenib through the same technology appraisal and currently expects to publish draft guidance in October 2017.

In the absence of NICE guidance, it is for commissioners to make funding decisions based on the available evidence and on the patient’s individual clinical circumstances.